The FDA assessed the security and efficiency of atidarsagene autotemcel based upon info from 37 little ones who received atidarsagene autotemcel in two one-arm, open-label scientific trials and in an expanded access program.[7] Kids who received procedure with atidarsagene autotemcel ended up when compared to untreated young children (all-natural h